Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unconventional Treatments for Chronic Inflammatory Demyelinating Polyneuropathy
Yusuf A. Rajabally
Neurodegenerative Disease Management (2017) Vol. 7, Iss. 5, pp. 331-342
Closed Access | Times Cited: 21

Showing 21 citing articles:

Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks
Yusuf A. Rajabally
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 99-110
Open Access | Times Cited: 5
Treatment response amplitude and timing in chronic inflammatory demyelinating polyneuropathy with routine care: Study of a UK cohort
Yusuf A. Rajabally, Young Gi Min, Kabir Khan Nazeer, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 10
Open Access | Times Cited: 5
The overlap of diabetic and inflammatory neuropathies: epidemiology, possible mechanisms, and treatment implications
Yusuf A. Rajabally, Young Sil Min
Clinical Neurology and Neurosurgery (2025) Vol. 249, pp. 108719-108719
Open Access
Management challenges for chronic dysimmune neuropathies during the COVID‐19 pandemic
Yusuf A. Rajabally, H. Stephan Goedee, Shahram Attarian, et al.
Muscle & Nerve (2020) Vol. 62, Iss. 1, pp. 34-40
Open Access | Times Cited: 21
S2e-Leitlinie: Therapie akuter und chronischer immunvermittelter Neuropathien und Neuritiden
Claudia Sommer
DGNeurologie (2018) Vol. 1, Iss. 2, pp. 89-103
Closed Access | Times Cited: 17
Inflammatory polyradiculoneuropathies: Clinical and immunological aspects, current therapies, and future perspectives
Vincenzo Di Stefano, Filomena Barbone, Camilla Ferrante, et al.
European Journal of Inflammation (2020) Vol. 18, pp. 205873922094234-205873922094234
Open Access | Times Cited: 11
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy
Farzad Fatehi, Ali Asghar Okhovat, Akram Panahi, et al.
Journal of the Peripheral Nervous System (2021) Vol. 26, Iss. 4, pp. 469-474
Closed Access | Times Cited: 9
Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression
Stefanie Kar Yan Hung, Fu Liong Hiew, Shanthi Viswanathan, et al.
Journal of the Peripheral Nervous System (2018) Vol. 23, Iss. 3, pp. 183-189
Closed Access | Times Cited: 6
General Principles of Immunotherapy in Neurological Diseases
Paulus Rommer, Michael Hecker, Tobias Zrzavy, et al.
Contemporary clinical neuroscience (2019), pp. 387-421
Closed Access | Times Cited: 5
Contemporary challenges in the diagnosis and management of chronic inflammatory demyelinating polyneuropathy
Yusuf A. Rajabally
Expert Review of Neurotherapeutics (2022) Vol. 22, Iss. 2, pp. 89-99
Closed Access | Times Cited: 3
Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins
Mengge Yang, Xu Li, Suqiong Ji, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 1207-1217
Open Access | Times Cited: 3
Chronic inflammatory demyelinating polyradiculoneuropathy in patients with diabetes mellitus - treatment with intravenous immunoglobulins: A systematic review
Szymon Andrusiów, Zuzanna Pawlak, Bartłomiej Stańczykiewicz, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114974-114974
Open Access | Times Cited: 1
Chronic Inflammatory Demyelinating Polyneuropathy as the Initial Presentation of Systemic Lupus Erythematosus Successfully Treated With Cyclophosphamide
A Martínez, María J Tróchez Ortiz, Lizeth V Zuluaga Gómez, et al.
Cureus (2024)
Open Access
General Principles of Immunotherapy in Neurological Diseases
Paulus Rommer, Michael Hecker, Tobias Zrzavy, et al.
Springer eBooks (2024), pp. 1-43
Closed Access
General Principles of Immunotherapy in Neurological Diseases
Paulus Rommer, Michael Hecker, Tobias Zrzavy, et al.
(2024), pp. 493-535
Closed Access
Tacrolimus treatment for relapsing-remitting chronic inflammatory demyelinating polyradiculoneuropathy: Two case reports
Wenjia Zhu, Yuwei Da, Hai Chen, et al.
World Journal of Clinical Cases (2022) Vol. 10, Iss. 5, pp. 1709-1715
Open Access | Times Cited: 2
Polyradiculoneuropathies inflammatoires démyélinisantes chroniques : mise au point diagnostique et thérapeutique
J. Franques
La Revue de Médecine Interne (2019) Vol. 40, Iss. 12, pp. 808-815
Closed Access | Times Cited: 1
Chronic inflammatory demyelinating polyneuropathy
Yusuf A. Rajabally, H. Stephan Goedee
Elsevier eBooks (2020), pp. 31-83
Closed Access | Times Cited: 1
Existing and Emerging Approaches to Treating Chronic Inflammatory Demyelinating Polyneuropathy
Brannagan III Thomas H, Khosro Farhad, Inna Kleyman, et al.
touchREVIEWS in Neurology (2019) Vol. 15, Iss. 1, pp. 33-33
Open Access
Carrefour des spécialités : autogreffe de cellules souches hématopoïétiques périphériques pour la prise en charge thérapeutique des polyradiculonévrites inflammatoires démyélinisantes chroniques
Fanny Urbain, Céline Labeyrie, Cristina Castilla‐Llorente, et al.
La Revue de Médecine Interne (2021) Vol. 42, Iss. 9, pp. 639-649
Closed Access
An Alternative Novel Therapy for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy: Adult Autologous Telomerase-Positive Stem Cells
Warren Young, Mark O Speight
Stem Cell & Regenerative Medicine (2021) Vol. 5, Iss. 2
Open Access
Page 1

Scroll to top